Therapeutic Stents Market Size, Share, Industry Trends and Forecast to 2030

Therapeutic Stents Market Size & CAGR in 2021

The global therapeutic stents market is projected to have a growth rate of 5.2% CAGR from 2021 to 2030. The market is expected to reach a value of USD 12.6 billion by 2028, showcasing steady growth over the forecast period.

COVID-19 Impact on the Therapeutic Stents Market

The COVID-19 pandemic had a significant impact on the therapeutic stents market. The global healthcare industry faced disruptions due to the pandemic, leading to delays in elective procedures such as stent implantations. However, as healthcare systems adapted to the new normal, the market witnessed a gradual recovery, driven by the resumption of elective surgeries and a focus on cardiovascular health.

Therapeutic Stents Dynamics

Therapeutic stents are medical devices used to treat narrowed or blocked blood vessels. These devices help restore blood flow and support the vessel walls, reducing the risk of heart attacks, strokes, and other cardiovascular complications. The market for therapeutic stents is driven by the increasing prevalence of cardiovascular diseases, technological advancements in stent design, and a growing elderly population prone to heart-related conditions.

Segments and Related Analysis

The therapeutic stents market can be segmented based on product type, material, end-user, and region. Product types include coronary stents, peripheral stents, and neurovascular stents. Materials used for stent manufacturing include metal, polymer, and bioresorbable materials. End-users of therapeutic stents include hospitals, cardiac centers, and ambulatory surgical centers.

By Region Analysis

The therapeutic stents market is analyzed based on regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America currently leads the market due to the presence of advanced healthcare infrastructure, high adoption of innovative medical technologies, and a significant patient pool requiring stent interventions. However, the Asia Pacific region is expected to witness the highest growth rate in the forecast period, driven by improving healthcare accessibility and rising cardiovascular disease prevalence.

Key Market Players and Competitive Landscape

Major players in the therapeutic stents market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, and B. Braun Melsungen AG. These companies focus on product innovation, strategic partnerships, and mergers to strengthen their market presence and offer advanced stent solutions to healthcare providers and patients.

Recent Happenings in the Therapeutic Stents Market

In recent developments, companies like Medtronic have launched next-generation drug-eluting stents with advanced coating technologies to improve patient outcomes. Abbott Laboratories introduced bioresorbable vascular scaffolds that dissolve over time, providing temporary support before completely disappearing from the body. These innovations aim to enhance the efficacy and safety of stent procedures, catering to the evolving needs of both clinicians and patients.